| Line Item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|---|---|
| Operating expenses | |||||
| General and administrative | |||||
| Consulting and professional fees | |||||
| Acquisition cost | |||||
| Investor relations and marketing | |||||
| Salaries and benefits | |||||
| Share-based payments (Note 17) | |||||
| Operating loss: | |||||
| Other | |||||
| Unrealized gain (loss) on marketable securities (Note 8) | |||||
| (Loss) gain on financial derivative liability – Convertible Notes (Note 11) | |||||
| Changes in fair value of US warrants (Note 14 and 17 (c)) | |||||
| Extinguishment of government loans | |||||
| Impairment | |||||
| Other non-operating loss (Note 19) | |||||
| Net loss |